临床试验中的中位随访时间。 - Suppr

Suppr

超能文献

Median follow-up in clinical trials.

作者信息

Shuster J J

出版信息

J Clin Oncol. 1991 Jan;9(1):191-2. doi: 10.1200/JCO.1991.9.1.191.

DOI:10.1200/JCO.1991.9.1.191

PMID:1985169

Abstract

摘要

相似文献

Median follow-up in clinical trials.临床试验中的中位随访时间。

J Clin Oncol. 1991 Jan;9(1):191-2. doi: 10.1200/JCO.1991.9.1.191.

[Methodology of clinical trials].[临床试验方法学]

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S13-6.

Combining symptom and survival data.结合症状和生存数据。

Curr Probl Cancer. 2006 Nov-Dec;30(6):307-18. doi: 10.1016/j.currproblcancer.2006.08.008.

Analysis of survival in cancer clinical trials.癌症临床试验中的生存分析。

Ann Intern Med. 1983 May;98(5 Pt 1):665-6. doi: 10.7326/0003-4819-98-5-665.

Controlled prophylactic trials in cancer.癌症的对照预防性试验。

J Natl Cancer Inst. 1980 Apr;64(4):693-9.

Size of phase III cancer clinical trials.III期癌症临床试验的规模。

Cancer Treat Rep. 1985 Oct;69(10):1087-93.

Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?总生存期：患者预后、治疗目标、临床试验终点还是公共卫生指标？

J Clin Oncol. 2012 May 20;30(15):1750-4. doi: 10.1200/JCO.2011.38.6359. Epub 2012 Mar 5.

Statistical considerations for the next generation of clinical trials.下一代临床试验的统计学考虑。

Semin Oncol. 2011 Aug;38(4):598-604. doi: 10.1053/j.seminoncol.2011.05.014.

Illusion and reality: practical pitfalls in interpreting clinical trials.幻想与现实：解读临床试验中的实际陷阱

J Clin Oncol. 1984 May;2(5):488-97. doi: 10.1200/JCO.1984.2.5.488.

Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.癌症临床试验中的资格排除、失访、随机分组患者的剔除以及未计数事件。

Cancer Treat Rep. 1985 Oct;69(10):1107-13.

引用本文的文献

Molecular Phenogroups in Heart Failure: Large-Scale Proteomics in a Population-Based Cohort.心力衰竭中的分子表型组：基于人群队列的大规模蛋白质组学研究

Circ Genom Precis Med. 2025 Jul 16:e004953. doi: 10.1161/CIRCGEN.124.004953.

Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy.接受化疗免疫治疗的三阴性乳腺癌低心血管风险患者的动态心脏变化

Cardiooncology. 2025 Jul 3;11(1):62. doi: 10.1186/s40959-025-00361-2.

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma.达雷妥尤单抗、环磷酰胺、沙利度胺和地塞米松用于新诊断多发性骨髓瘤的2期试验。

Blood Neoplasia. 2025 Mar 3;2(3):100081. doi: 10.1016/j.bneo.2025.100081. eCollection 2025 Aug.

Prognostic factors in ALS: different approaches to the same problem.肌萎缩侧索硬化症的预后因素：针对同一问题的不同方法。

Arq Neuropsiquiatr. 2025 Jun;83(6):1-7. doi: 10.1055/s-0045-1809407. Epub 2025 Jun 20.

Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials.早期全治疗方案治疗的多发性骨髓瘤患者的长期随访：三项临床试验的二次分析

JAMA Oncol. 2025 Jun 5. doi: 10.1001/jamaoncol.2025.1394.

P2Y inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.经皮冠状动脉介入治疗后使用P2Y抑制剂或阿司匹林：随机临床试验的个体患者数据荟萃分析

BMJ. 2025 Jun 4;389:e082561. doi: 10.1136/bmj-2024-082561.

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.CONSORT 2025解释与阐述：随机对照试验报告的更新指南

BMJ. 2025 Apr 14;389:e081124. doi: 10.1136/bmj-2024-081124.

Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil.资金来源对前列腺癌长期预后的影响：来自巴西圣保罗的大型公共数据库分析

JCO Glob Oncol. 2025 Feb;11:e2400271. doi: 10.1200/GO-24-00271. Epub 2025 Feb 6.

Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients.新辅助治疗后从腋窝清扫术转向靶向腋窝手术：114例单中心隐匿性乳腺癌患者的治疗进展

Breast Cancer Res Treat. 2025 Apr;210(3):661-672. doi: 10.1007/s10549-024-07604-3. Epub 2025 Jan 8.

Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.医疗保健系统作为多发性骨髓瘤预后的决定因素：拉丁美洲MYLACRE研究的最终结果

Blood Adv. 2025 Mar 25;9(6):1293-1302. doi: 10.1182/bloodadvances.2024013838.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验